NCT07321431

Brief Summary

This is a multicenter, prospective, randomized, double-blind, crossover study involving healthy individuals, aiming to evaluate the stability of oral protein bars + olive oil as a new method for determining gallbladder contraction function and its optimal diagnostic time window.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jan 2026

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Dec 2026

First Submitted

Initial submission to the registry

December 13, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 7, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2026

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

December 13, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

Gallbladder Contractile FunctionUltrasound ExaminationOlive oilProtein BarOptimal time

Outcome Measures

Primary Outcomes (2)

  • Gallbladder Volume

    Formula for Ultrasound Measurement of Gallbladder Volume (L × W × D × 0.52). Measurements were taken every 20 minutes starting from 30 minutes after the intervention, with a total of 5 measurements (i.e., the gallbladder volume was measured at 30 minutes, 50 minutes, 70 minutes, 90 minutes, and 110 minutes respectively).

    during procedure

  • Gallbladder contraction rate

    Subtract the volume of the gallbladder after intervention from the volume of the gallbladder on an empty stomach, then divide by the volume of the gallbladder on an empty stomach, and finally multiply by A-B/A%. The gallbladder contraction rate was calculated at all the above time points.

    during procedure

Secondary Outcomes (3)

  • Presence of Abdominal

    30 days

  • Occurrence of Acute Pancreatitis

    30 days

  • Occurrence of Gastrointestinal Bleeding Post-Intervention

    30 days

Study Arms (2)

fried eggs

EXPERIMENTAL

First, the intervention of oral administration of 2 fried eggs is carried out. The size of the gallbladder is evaluated by ultrasound examination. The washout period is 1 week. After that, the first intervention process of group B is repeated.

Dietary Supplement: oral administration of 2 fried eggs

protein bars

ACTIVE COMPARATOR

First, an intervention with oral protein bars + 50ml olive oil is conducted. The size of the gallbladder is evaluated through ultrasound examination. The washout period is 1 week. After that, the first intervention process of Group A is repeated.

Dietary Supplement: oral protein bars + 50ml olive oil

Interventions

First, the intervention of oral administration of 2 fried eggs is carried out. The size of the gallbladder is evaluated by ultrasound examination. The washout period is 1 week. After that, the first intervention process of group B is repeated.

fried eggs

First, an intervention with oral protein bars + 50ml olive oil is conducted. The size of the gallbladder is evaluated through ultrasound examination. The washout period is 1 week. After that, the first intervention process of Group A is repeated.

protein bars

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ultrasound assessment identifies people with normal biliary tract structure.

You may not qualify if:

  • History of Endoscopic Retrograde Cholangiopancreatography
  • Previous gallstone removal surgery with gallbladder preservation
  • Other biliary tract diseases and related surgical history
  • History of acute or chronic pancreatitis
  • History of gastrointestinal surgery
  • Gastrointestinal obstruction
  • Dysfunction of the sphincter of Oddi
  • Gallbladder neck polyps
  • Abnormal gallbladder structure
  • Gallbladder mass
  • Biliary infection or stones
  • Congenital biliary abnormalities
  • Biliary injury or surgery
  • Biliary tumors
  • Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Hepatopancreatobiliary Surgery Institute of Gansu Province

Lanzhou, Gansu, 730000, China

RECRUITING

The First Hospital of Qinhuangdao

Qinhuangdao, Hebei, 066000, China

RECRUITING

The Jinqiu Hospital of Liaoning Province

Shenyang, Liaoning, 110016, China

RECRUITING

People's Hospital of Ningxia Hui Autonomous Region

Yinchuan, Ningxia, 750011, China

RECRUITING

Honghui Hospital of Xi'an Jiaotong University

Xi’an, Shanxi, 710054, China

RECRUITING

Related Publications (2)

  • Ai XN, Wang TF, Zhang Q, Ouyang CG, Wu ZY. Changes in Gallbladder Contractile Function and its Influencing Factors After Minimally Invasive Gallbladder-Preserving Surgery for Cholecystitis With Incarcerated Gallstones. Front Surg. 2022 Jul 14;9:926141. doi: 10.3389/fsurg.2022.926141. eCollection 2022.

    PMID: 35910468BACKGROUND
  • Rehfeld JF. Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab. 2004 Dec;18(4):569-86. doi: 10.1016/j.beem.2004.07.002.

    PMID: 15533776BACKGROUND

MeSH Terms

Interventions

Olive Oil

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFats, UnsaturatedPlant OilsOilsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Wenbo Meng, M.D. Ph. D.

    Hepatopancreatobiliary Surgery Institute of Gansu Province

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wenbo Meng, M.D. Ph. D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The PI, study biostatistician will be masked until database lock.
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: A two-period crossover design will be adopted, in which the two intervention methods will be randomly assigned.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Surgery

Study Record Dates

First Submitted

December 13, 2025

First Posted

January 7, 2026

Study Start

January 7, 2026

Primary Completion (Estimated)

December 20, 2026

Study Completion (Estimated)

December 20, 2026

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations